Document Detail


Effects of black cohosh extract on body weight gain, intra-abdominal fat accumulation, plasma lipids and glucose tolerance in ovariectomized Sprague-Dawley rats.
MedLine Citation:
PMID:  18691839     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Extracts of the black cohosh (Actaea/Cimicifuga racemosa (CR)) have long been used to treat estrogen deficiency symptoms in women after menopause. Recent data from randomized controlled studies have shown that CR consumption alleviates "hot flushes" and due to the lack of uterotropic effects can be a safe alternative to estrogen replacement therapy. OBJECTIVE: To evaluate the effects of dietary CR extract consumption on body weight (BW) gain, intra-abdominal fat (IAF) accumulation, plasma leptin, lipids and glucose tolerance in ovariectomized rats and to compare them with the effects of 17beta-estradiol. DESIGN: Twenty-seven female Sprague-Dawley rats were ovariectomized and fed soy-free chow with the addition of estradiol-3 benzoate (E2B) (10mg/kg, n = 10) or CR BNO 1055 extract (6.67 g/kg, n = 9). The control group (n = 8) received soy-free chow only. Weight and food intake were recorded once a week. After 6 weeks, intra-abdominal fat was measured using computer tomography and the intraperitoneal glucose tolerance test was performed. In the seventh week of the experiment animals were sacrificed, blood was collected for plasma and uteri were removed. RESULTS: Dietary CR BNO 1055 extract had no effects on uterine mass but significantly reduced serum lutenizing hormone (LH) levels (P < 0.05). Although, the average weekly food consumption throughout the experiment (calculated in g/kg of BW) did not differ between our studied groups, E2B or CR BNO 1055 treated animals gained less weight and had significantly less IAF accumulation compared to control animals (P < 0.05). E2B treatment also decreased plasma total (T-,) high-density lipoprotein (HDL-) and low-density lipoprotein (LDL)-cholesterol (P < 0.05). Plasma T-Ch levels in CR BNO 1055 treated animals did not differ from the controls whereas LDL-Ch levels were significantly higher and plasma triglycerides (TG) significantly lower (P<0.05). In the glucose tolerance test, the area under the curve (AUC) was significantly smaller in the E2B treated animals compared to controls (P<0.05). AUC in CR BNO 1055 treated animals did not differ significantly from the controls (P>0.05). Nevertheless, fasting plasma insulin (FPI) levels were significantly lower in E2B and CR BNO 1055 treated animals (P<0.05). CONCLUSIONS: In OVX rats, CR BNO 1055 extract consumption decreases enhanced pituitary LH secretion, attenuates body weight gain and IAF accumulation, lowers FPI and has no effects on uterine mass. The effects on plasma lipids seem to be more complex and are characterized by an increase of LDL-Ch and decrease of TG levels which is in contrast to the effects of estrogen.
Authors:
Dominik Rachoń; Tina Vortherms; Dana Seidlová-Wuttke; Wolfgang Wuttke
Related Documents :
20486439 - Soy isoflavone and its effect to regulate hypothalamus and peripheral orexigenic gene e...
9839809 - Partial replacement of dietary casein with soy protein isolate can reduce the severity ...
16751839 - The isoflavone content of commercially-available feline diets in new zealand.
3760999 - Bioavailability of zinc to rats as affected by protein source and previous dietary intake.
15539259 - Effects of isoflavones containing soy protein isolate compared with fish protein on ser...
3794819 - Plasma, tissue and fecal cholesterol of young pigs fed restricted or liberal amounts of...
15526409 - Dietary sesame oils inhibits iron-induced oxidative stress in rats [corrected]
25465539 - Feeding characteristics and rumination time of dairy cows around estrus.
18390899 - Uraemic hyperparathyroidism causes a reversible inflammatory process of aortic valve ca...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2008-08-08
Journal Detail:
Title:  Maturitas     Volume:  60     ISSN:  0378-5122     ISO Abbreviation:  Maturitas     Publication Date:    2008 Jul-Aug
Date Detail:
Created Date:  2008-10-17     Completed Date:  2009-02-12     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7807333     Medline TA:  Maturitas     Country:  Ireland    
Other Details:
Languages:  eng     Pagination:  209-15     Citation Subset:  IM    
Affiliation:
Department of Clinical and Experimental Endocrinology, University of Göttingen, Göttingen, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Body Weight / drug effects*
Cholesterol / blood
Cimicifuga
Disease Models, Animal
Estradiol / analogs & derivatives,  pharmacology
Female
Glucose Tolerance Test*
Intra-Abdominal Fat / drug effects*
Leptin / blood
Ovariectomy
Phytoestrogens / pharmacology*
Plant Extracts / pharmacology*
Postmenopause / drug effects
Rats
Rats, Sprague-Dawley
Triglycerides / blood
Chemical
Reg. No./Substance:
0/Cimicifuga extract BNO 1055; 0/Leptin; 0/Phytoestrogens; 0/Plant Extracts; 0/Triglycerides; 50-28-2/Estradiol; 50-50-0/estradiol 3-benzoate; 57-88-5/Cholesterol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Estrous synchrony in a group of African elephants (Loxodonta africana) under human care.
Next Document:  Variability of fingerprint ridge density in a sample of Spanish Caucasians and its application to se...